Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:05 PM
Ignite Modification Date:
2025-12-24 @ 1:05 PM
NCT ID:
NCT04409561
Eligibility Criteria:
Inclusion Criteria:
1. Male or female, aged ≥ 18 years.
2. Apparently healthy as determined by a subject questionnaire.
Exclusion Criteria:
1\) Current diagnosis, or history, of any underlying major medical condition determined by the investigator, including but not limited to:
1. Heart disease
2. Stroke
3. Renal disease
4. Liver disease
5. Pancreatic disease
6. Chronic obstructive pulmonary disorder
7. Bleeding disorders
8. Hypercalcitoninemia
9. HIV AIDS
10. Receiving antibiotic therapy
11. Suspected infection
12. Immunosuppression
2\) Underwent procedures related to sepsis, or diagnosed with sepsis, within the last 12 months.
3\) Current diagnosis of uncontrolled hypertension, hypotension, or diabetes.
4\) Diagnosis of bacterial, fungal, or malaria infection within the last 3 months that required antimicrobial treatment.
5 )Experienced severe trauma, surgery, cardiac shock, or severe burn within the previous 3 months requiring medical care.
6\) Current diagnosis of cancer within the last 12 months.
7\) Received immunotherapy to stimulate or inhibit cytokines within the last 12 months.
8\) Hospitalization for more than 24 hours within the last 3 months.
9\) Reported as currently pregnant or nursing a child
10\) Unable or unwilling to provide the required blood sample for testing.
11\) Any other criteria that, in the opinion of the investigator, would render the participant unsuitable for inclusion in the trial.
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04409561
Study Brief:
Protocol Section:
NCT04409561